Schonfeld Strategic Advisors »

Protagonist Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 89k 22.93
2023-09-30 $2.6M 154k 16.68
2023-03-31 $3.4M 149k 23.00
2022-09-30 $268k 32k 8.42
2022-06-30 $380k 48k 7.91
2022-03-31 $325k 14k 23.72
2021-06-30 $224k 5.0k 44.80
2019-06-30 $1.2M 102k 12.11
2019-03-31 $301k 24k 12.54